Israel Ortega Sánchez, M.D., Ph.D.

Gynecologist and Reproductive Medicine Specialist at IVI Madrid

IVI Madrid

Israel Ortega Sánchez, M.D., Ph.D.

Biography

Dr. Israel Ortega graduated from Complutense University School of Medicine in 2004 and received his Obstetrics and Gynecology Board certification from Autonoma University, Hospital La Paz in 2009. He is been working as a consultant in Reproductive Medicine at Instituto Valenciano de Infertilidad (IVI) since 2009. From 2010 to 2011 he studied at University of California, Davis (USA), under a Reproductive Endocrinology and Infertility Fellowship, receiving his PhD in 2014.

Dr. Israel Ortega’s main interest is PCOS, publishing several articles and chapters in scientific journals on this subject. He has received Honors Degree in Medicine (Complutense University of Madrid) and the First Prize Poster Award of the American Society for Reproductive Medicine.


Read more

Education and Training

M.D. Complutense University of Madrid Medical School, Madrid, Spain (2004)
Residency in Obstetrics and Gynecology La Paz Hospital, Madrid, Spain (2004)
Expert Degree in Clinical Genetics Alcala de Henares University, Madrid (2009)
Postdoctoral Fellowship: Reproductive Endocrinology, Department of Obstetrics and Gynecology University of California Davis School of Medicine, California USA (2010-2011)
Ph.D. Rey Juan Carlos University of Madrid Medical School, Madrid, Spain (2014)

Honors and recognition

First Prize Paper, Society for Reproductive Endocrinology and Infertility 2016
Ph.D Extraordinary Award, Rey Juan Carlos University of Madrid Medical School Madrid, Spain 2014
First Prize Poster, American Society for Reproductive Medicine 2011
Extraordinary Award for Degree in Medicine, Complutense University of Madrid 2003-2004

Publications


  • Sigue habiendo indicaciones para el ciclo natural?
    Castro B, Ortega I.
    2017

  • Using donor gametes, embryos.
    Iglesias C, Ortega I, Garcia Velasco JA.
    2016

  • High responder: optimizing your stimulation without complications.
    Martinez Salazar J, Ortega I, Garcia Velasco JA.
    2016

  • Ovarian actions of resveratrol.
    Ortega I, Duleba AJ.
    Ann N Y Acad Sci, 2015.

  • Progesterone supplementation in the frozen embryo transfer cycle.
    Ortega I, García Velasco JA.
    Curr Opin Obstet Gynecol. 2015

  • ART & PCOS.
    Ortega I, García Velasco JA.
    2015

  • Large bilateral endometrioma in IVF.
    García Velasco JA, Ortega I.

  • Endometriosis and ART.
    Ortega I, García Velasco JA.

  • Comparison of effects of different statins on growth and steroidogenesis of rat ovarian theca-interstitial cells.
    Sokalska A, Villanueva JA, Stanley SD, Ortega I, Duleba AJ.
    Biol Reprod, 2014.

  • Role of statins in PCOS management.
    Ortega I, Duleba AJ.
    Chapter 11, pp 181-203. Editor: Lubna Pal. Springer, 2014.


  • Resveratrol potentiates the inhibition of simvastatin on rat ovarian theca-intertitial cell steroidogenesis.
    Ortega I, Villanueva JA, Cress AB, Wong DH, Sokalska A, Stanley SD, Duleba AJ
    J Ovarian Res, 2014.

  • Effects of simvastatin on retinoic acid system in primary human endometrial stromal cells and in a chimeric model of human endometriosis.
    Sokalska A, Anderson M, Villanueva JA, Ortega I, Bruner-Tran KL, Osteen KV, Duleba AJ
    J Clin Endocrinol Metabol, 2013.

  • Resveratrol potentiates effect of simvastatin on inhibition of mevalonate pathway in human endometrial stromal cells.
    Villanueva JA, Sokalska A, Cress AB, Ortega I, Bruner-Tran KL, Osteen KV, Duleba AJ
    J Clin Endocrinol Metabol, 2013.

  • Simvastatin decreases invasiveness of human endometrial stromal cells.
    Sokalska A, Cress AB, Bruner-Tran KL, Osteen KV, Taylor HS, Ortega I, Duleba AJ
    Biol Reprod, 2012.

  • Resveratrol reduces steroidogenesis in rat ovarian theca-intertitial cells: the role of Akt/PKB signaling pathway.
    Ortega I, Villanueva JA, Cress AB, Wong DH, Sokalska A, Stanley SD, Duleba AJ
    Endocrinology, 2012.

  • Effects of resveratrol on growth and function of rat ovarian granulosa cells.
    Ortega I, Wong DH, Villanueva JA, Cress AB, Sokalska A, Stanley SD, Duleba AJ
    Fertil Steril, 2012.

  • Letrozole increases ovarian growth and CYP17A1 gene expression in the rat ovary. Ortega I, Villanueva JA, Sokalska A, Cress AB, Wong DH, Stener-Victorin E, Stanley SD, Duleba AJ .
    Fertil Steril, 2012.

  • Simvastatin reduces steroidogenesis by inhibiting CYP17A1 gene expression in rat ovarian theca-interstitial cells.
    Ortega I, Cress AB, Wong DH, Villanueva JA, Sokalska A, Moeller BC, Stanley SD, Duleba AJ.
    Biol Reprod, 2012.

  • Resveratrol inhibits HMG-CoA reductase expression and cholesterol synthesis in rat ovarian theca-interstitial cells: an interaction with simvastatin.
    Wong DH, Villanueva JA, Cress AB, Sokalska A, Ortega I, Duleba AJ
    Fertil Steril, 2011.

  • Anovulation.
    Ortega I, Requena A.
    Chapter 25.2, pp 397-398. In: R Matorras, J Remohí and V Serra (eds). Case Reports in Obstetrics and Gynecology. Panamericana, Madrid, Spain. 2011.

  • Case report: concurrent gynocologic neoplasia of cervix, ovary and fallopian tube.
    Castro B, Ortega I, De Santiago J, Hernández A.
    Rev Chil Obstet Ginecol, 76(6):417-419, 2011.

  • Lymph node involvement in a patient with deep infiltrating endometriosis.
    Ortega I, Castro B, De Santiago J, Hernández A, Benito DM, Ordás J
    Rev Chil Obstet Ginecol 74(5): 303 – 306, 2009.


Read more
Close Menu